Hypera Pharma News Today

HYPERA S.A. A Publicly-Held Corporation CNPJ/MF No. 02.932.074/0001-91 NIRE 35.300.353.251 CVM...

For more than 100 years, it has been believed that sunlight and vitamin D deficiency were associated with the risk for many deadly cancers including colorectal, prostate and breast. But some scientists remained skeptical that this nutrient provides any benefit for reducing cancer risk and morbidity and mortality and several randomized controlled trials that have supported this doubt. However, in a new commentary in JAMA Network Open, Michael F. Holick, PhD, MD, professor of medicine, pharmacol...

- Continued Commercial Momentum Within Core Cannabinoid Markets - Clever Leaves Holdings Inc.

Rafael Mendes, Chief Compliance Officer at Novonor (former Odebrecht), talks about the initiatives the company implemented in the last years to transform its governance. He also discussed the compliance events Novonor is leading with other organizations

In recent years – and notwithstanding encouraging windows of progress – economic difficulties, political shifts, and the pandemic's lingering effects have undercut anti-corruption efforts in Latin America.

Takedas latest sale brings its total divestment value up to about $12.9 billion. (Takeda) After inking a slate of geography-specific product selloffs last year, Takeda has turned back to Japan. Takeda locked up a deal to sell four Type 2 diabetes meds in Japan to local drugmaker Teijin Pharma for 133 billion Japanese yen ($1.2 billion), freeing up the company to focus on its core businesses in gastroenterology, rare diseases, plasma-derived therapies, oncology and neuroscience. The move is the ...

Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum 2020’s headlines have been dominated by coronavirus since the first reports of a mysterious virus causing pneumonia in Wuhan, China, in January. The pharmaceuticals sector’s response was huge. While the pharma landscape has been somewhat unusual this year, at least some business has carried on. The need for effective and innovative ways to treat disease is something that even a global pandemic will...